Treatment of advanced (Stages III and IV) non—small-cell lung cancer

Landis, 1998, Cancer statistics, 1998, CA Cancer J Clin, 48, 6, 10.3322/canjclin.48.1.6 Friese, 1978, Bronchial carcinoma and long term survival, Thorax, 33, 228, 10.1136/thx.33.2.228 Mountain, 1997, Revisions in the International Staging System for lung cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710 McLoud, 1992, Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling, Radiology, 182, 319, 10.1148/radiology.182.2.1732943 Lewis, 1990, Can computed tomography of the chest stage lung cancer: yes and no, Ann Thorac Surg, 49, 591, 10.1016/0003-4975(90)90306-Q Mussett, 1986, Primary lung cancer staging: prospective comparative study of MR imaging with CT, Radiology, 160, 607, 10.1148/radiology.160.3.2426726 Martini, 1985, Comparative merits of conventional, computed tomographic and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma, J Thorac Cardiovasc Surg, 90, 639, 10.1016/S0022-5223(19)38529-0 Broderick, 1997, Imaging of lung cancer: old and new, Semin Oncol, 24, 411 Gallagher, 1978, Metabolic trapping as a principle of radiopharmaceutical design: some factors responsible for the biodistribution of (18F) 2 deoxy-2-fluoro-D-glucose, J Nucl Med, 19, 1154 Patz, 1993, Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning, Radiology, 188, 487, 10.1148/radiology.188.2.8327702 Valk, 1995, Staging lung cancer by metabolic PET imaging, 14, A1060 Gress, 1997, Endoscopic ultrasound, endoscopically directed fine needle aspiration and computed tomography in the preoperative staging of non-small cell lung cancer: a comparative study, Ann Intern Med, 127, 604, 10.7326/0003-4819-127-8_Part_1-199710150-00004 Weisenburger, 1986, The Lung Cancer Study Group: effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung, N Engl J Med, 315, 1377, 10.1056/NEJM198611273152202 Stephens, 1996, The role of postoperative radiotherapy in non-small cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1–2, N1–2, M0 disease, Br J Cancer, 74, 632, 10.1038/bjc.1996.413 Sawyer, 1997, The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement, Cancer, 80, 1399, 10.1002/(SICI)1097-0142(19971015)80:8<1399::AID-CNCR6>3.0.CO;2-A Holmes, 1986, The Lung Cancer Study Group: surgical adjuvant therapy for stage II and stage III adenocarcinoma and large cell undifferentiated carcinoma, J Clin Oncol, 4, 710, 10.1200/JCO.1986.4.5.710 Holmes, 1993, Postoperative chemotherapy for non-small cell lung cancer, Chest, 103, 30S, 10.1378/chest.103.1_Supplement.30S Einhorn, 1993, Neoadjuvant and adjuvant trials in non-small cell lung cancer, 111 Lad, 1988, The Lung Cancer Study Group: the benefit of adjuvant treatment for resecte locally advanced non-small cell lung cancer, J Clin Oncol, 6, 9, 10.1200/JCO.1988.6.1.9 Pisters, 1993, Randomized trial of postoperative vindesine and cisplatin in patients with stage III (T1–3N2M0) non-small cell lung cancer, 118 Ohta, 1993, Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer: results of a randomized prospective study, J Thorac Cardiovasc Surg, 106, 703, 10.1016/S0022-5223(19)33714-6 Dautzenberg, 1995, Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma, Cancer, 76, 779, 10.1002/1097-0142(19950901)76:5<779::AID-CNCR2820760511>3.0.CO;2-O Stewart, 1995, Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials, Br Med J, 311, 899, 10.1136/bmj.311.7010.899 Shields, 1970, Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma, J Thorac Cardiovasc Surg, 59, 49, 10.1016/S0022-5223(19)42513-0 Warram, 1975, Preoperative irradiation of cancer of the lung: final report of the therapeutic trial, Cancer, 36, 914, 10.1002/1097-0142(197509)36:3<914::AID-CNCR2820360312>3.0.CO;2-Q Murren, 1991, Critical analysis of neoadjuvant therapy for stage IIIa non-small cell lung cancer, Am Rev Respir Dis, 143, 889, 10.1164/ajrccm/143.4_Pt_1.889 Ruckdeschel, 1997, Combined modality therapy of non-small cell lung cancer, Semin Oncol, 24, 429 Roth, 1994, A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage III non-small cell lung cancer, J Natl Cancer Inst, 86, 673, 10.1093/jnci/86.9.673 Rosell, 1994, A randomized trial comparing preoperative chemotherapy with surgery alone in patients with non-small cell lung cancer, N Engl J Med, 330, 153, 10.1056/NEJM199401203300301 Pass, 1992, Randomized trial of neoadjuvant therapy for lung cancer: interim analysis, Ann Thorac Surg, 53, 992, 10.1016/0003-4975(92)90373-C Albain, 1995, Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group Phase II study 8805, J Clin Oncol, 13, 1880, 10.1200/JCO.1995.13.8.1880 Ihde, 1991, Non-small cell lung cancer. Part II: treatment, Curr Probl Cancer, 15, 109, 10.1016/0147-0272(91)90012-Y Trovo, 1992, Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer, Int J Radiat Oncol Biol Phys, 24, 11, 10.1016/0360-3016(92)91014-E Blanke, 1995, A phase III trial of thoracic irradiation with or without cisplatin for locally advanced non-small cell lung cancer (NSCLC): a Hoosier Oncology Group (HOG) protocol, J Clin Oncol, 13, 1425, 10.1200/JCO.1995.13.6.1425 Mattson, 1988, Inoperable non-small cell lung cancer: radiation with or without chemotherapy, Eur J Clin Oncol, 24, 477, 10.1016/S0277-5379(98)90020-7 Morton, 1991, Thoracic radiation therapy compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer: a randomized, phase III trial, Ann Intern Med, 115, 681, 10.7326/0003-4819-115-9-681 Dillman, 1990, A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer, N Engl J Med, 323, 940, 10.1056/NEJM199010043231403 Dillma, 1996, Improved survival in stage III non-small cell lung cancer: seven year follow-up of Cancer and Leukemia Group B (CALG), J Natl Cancer Inst, 88, 1210, 10.1093/jnci/88.17.1210 Sause, 1995, preliminary results of a phase III trial in regionally advanced, 87, 198 Komaki, 1997, Induction cisplatin/vinblastine and irradiation vs irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG/88-08/ECOG 4588, Int J Radiat Oncol Biol Phys, 39, 537, 10.1016/S0360-3016(97)00365-9 Jeremic, 1995, Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer, Clin Oncol, 13, 452, 10.1200/JCO.1995.13.2.452 LeChevalier, 1991, Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients, J Natl Cancer Inst, 83, 417, 10.1093/jnci/83.6.417 LeChevalier, 1992, Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma, J Natl Acad Inst, 84, 58, 10.1093/jnci/84.1.58 Schaake-Koning, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer, N Engl J Med, 326, 524, 10.1056/NEJM199202203260805 Pritchard, 1996, Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer: a meta-analysis, Ann Intern Med, 125, 723, 10.7326/0003-4819-125-9-199611010-00003 Furuse, 1997, A randomized phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with mitomycin C (M), vindesine (V), and cisplatin in unresectable stage III non-small cell lung cancer (NSCLC): preliminary analysis, 16, A1649 Saunders, 1990, Continuous hyperfractionated, accelerated radiotherapy (CHART) in non-small cell lung carcinoma of the bronchus, Int J Radiat Oncol Biol Phys, 19, 1211, 10.1016/0360-3016(90)90231-8 Vogl, 1982, Efficacy study of intensive cisplatin therapy in advanced non-small cell bronchogenic carcinoma, Cancer, 50, 24, 10.1002/1097-0142(19820701)50:1<24::AID-CNCR2820500106>3.0.CO;2-R Samson, 1978, Motomycin C in advanced adenocarcinoma and large cell carcinoma of the lung, Cancer Treat Rep, 62, 163 Harrison, 1982, Sigle dose ifosfamide: efficacy studies in non-small cell lung cancer, Semin Oncol, 9, 56 Furnas, 1982, Vindesine: an effective agent in the treatment of non-small cell lung cancer, Cancer Treat Rep, 66, 1709 Schulman, 1982, Phase II study of divided-dose vinblastine in non-small cell bronchogenic carcinoma, Cancer Treat Rep, 66, 171 Bonomi, 1989, Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small cell lung cancer: a study of the Eastern Cooperative Oncology Group, J Clin Oncol, 7, 1602, 10.1200/JCO.1989.7.11.1602 Ruckdeschel, 1986, A randomized trial of the four most active regimens for metastatic non-small cell lung cancer, J Clin Oncol, 4, 14, 10.1200/JCO.1986.4.1.14 Einhorn, 1986, Randomized prospective study of vindesine versus vindesine plus platinum plus mitomycin in advanced non-small cell lung cancer, J Clin Oncol, 4, 1037, 10.1200/JCO.1986.4.7.1037 Klastersky, 1986, A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small cell lung carcinoma, J Clin Oncol, 4, 1780, 10.1200/JCO.1986.4.12.1780 Buccheri, 1994, A randomized trial of MACC chemotherapy with or without lonidamide in advanced non-small lung cancer, Eur J Cancer, 30, 1424, 10.1016/0959-8049(94)00286-E Crino, 1995, Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.), Ann Oncol, 6, 347, 10.1093/annonc/6.suppl_3.S45 Klastersky, 1990, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small cell lung cancer: European organization for research and treatment of cancer protocol 07861, J Clin Oncol, 8, 1556, 10.1200/JCO.1990.8.9.1556 Klastersky, 1989, Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer, J Clin Oncol, 7, 1087, 10.1200/JCO.1989.7.8.1087 Longeval, 1982, Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma: a study by the EORTC Lung Cancer Working Party (Belgium), Cancer, 50, 2751, 10.1002/1097-0142(19821215)50:12<2751::AID-CNCR2820501210>3.0.CO;2-3 Albain, 1991, Survival determinants in extensive-stage non-small cell lung cancer: the Southwest Oncology Group experience, J Clin Oncol, 9, 1618, 10.1200/JCO.1991.9.9.1618 Paesmans, 1995, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1053 patients, J Clin Oncol, 13, 1221, 10.1200/JCO.1995.13.5.1221 Rapp, 1988, Chemotherapy can prolong survival in patients with advanced non-small lung cancer: report of a Canadian multicenter randomized trial, J Clin Oncol, 6, 633, 10.1200/JCO.1988.6.4.633 Jaakimainen, 1990, Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized controlled trial in non-small cell lung cancer, J Clin Oncol, 3, 1301, 10.1200/JCO.1990.8.8.1301 Cartei, 1993, Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small lung cancer, J Natl Cancer Inst, 85, 794, 10.1093/jnci/85.10.794 Woods, 1990, A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small lung cancer, Br J Cancer, 61, 608, 10.1038/bjc.1990.135 Cellerino, 1991, A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small cell lung cancer, J Clin Oncol, 9, 1453, 10.1200/JCO.1991.9.8.1453 Marino, 1994, Chemotherapy versus supportive care in advanced non-small lung cancer: results of a meta-analysis of the literature, Chest, 106, 861, 10.1378/chest.106.3.861 Mason, 1980, Mitomycin, vinblastine and cisplatin combination chemotherapy in non-small cell lung cancer, 21, A477 Eagan, 1977, Platinum based polychemotherapy versus clear hydrogolactitol in advanced non-small cell lung cancer, Cancer Treat Rep, 61, 1339 Schiff, 1979, Promotion of microtubule assembly in vitro by taxol, Nature, 22, 665, 10.1038/277665a0 Tishler, 1992, Taxol: a novel radiation sensitizer, Int J Radiat Oncol Biol Phys, 22, 613, 10.1016/0360-3016(92)90888-O Chang, 1993, Phase II study of taxol, merbarone and piroxantrone in stage IV non-small cell lung cancer: the Eastern Cooperative Oncology Group Results, J Natl Cancer Inst, 85, 388, 10.1093/jnci/85.5.388 Murphy, 1993, Phase II study of Taxol in patients with untreated advanced non-small cell lung cancer, J Natl Cancer Inst, 85, 384, 10.1093/jnci/85.5.384 Gatzemeier, 1995, Chemotherapy of advanced inoperable non-small cell lung cancer with paclitaxel: a phase II trial, Semin Oncol, 22, 24 Millward, 1996, Phase II trial of a 3 hour infusion of paclitaxel in previously untreated patients with advanced non-small cell lung cancer, J Clin Oncol, 14, 142, 10.1200/JCO.1996.14.1.142 Ringel, 1991, Studies with RP56976 (Taxotere): a semisynthetic analogue of Taxol, J Natl Cancer Inst, 83, 288, 10.1093/jnci/83.4.288 Watanabe, 1994, Phaes II trial of docetaxel in previously untreated non-small lung cancer (NSCLC), 13, A1095 Fossella, 1994, Phase II study of docetaxel for recurrent or metastatic non-small cell lung cancer, J Clin Oncol, 12, 1238, 10.1200/JCO.1994.12.6.1238 Cerny, 1994, Docetaxe (Taxotere) is active in non-small cell lung cancer: a phase II trial of the EORTC Early Clinical Trials Group (ECTG), Br J Cancer, 70, 384, 10.1038/bjc.1994.311 Burris, 1993, Phase II trials of Taxotere in patients with non-small cell lung cancer, 12, A1116 Miller, 1995, Phase II trial of a 75 mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer, Cancer, 75, 968, 10.1002/1097-0142(19950215)75:4<968::AID-CNCR2820750411>3.0.CO;2-Y Francis, 1994, Phase II trial of docetaxel in patients with stage II and IV non-small cell lung cancer, J Clin Oncol, 12, 1238, 10.1200/JCO.1994.12.6.1238 Lira Puerto, 1995, Phase II trial of (Taxotere) docetaxel in advanced non-small cell lung cancer, 14, A1186 Grunewald, 1990, Pharmacologically directed design of the dose rate and schedule of 2′2′-difluorodeoxycytidine (gemcitabine) administration in leukemia, Cancer Res, 50, 6823 Anderson, 1994, Single agent activity of weekly gemcitabine in advanced non-small cell lung cancer: a phase II study, J Clin Oncol, 12, 1821, 10.1200/JCO.1994.12.9.1821 Gatzemeier, 1996, Activity of gemcitabine in patients with non-small cell lung cancer: a multicentre, extended phase II study, Eur J Cancer, 32A, 243, 10.1016/0959-8049(95)00444-0 Abratt, 1994, Efficacy and safety profile of gemcitabine in non-small cell lung cancer: a phase II study, J Clin Oncol, 12, 1535, 10.1200/JCO.1994.12.8.1535 Slichenmyer, 1993, The current status of camptothecin analogues as anticancer agents, J Natl Cancer Inst, 85, 271, 10.1093/jnci/85.4.271 Fukuoka, 1992, A phase II study of CPT-11, a camptothecin derivative, for previously untreated non-small cell lung cancer, J Clin Oncol, 10, 16, 10.1200/JCO.1992.10.1.16 Negoro, 1991, A phase II study of CPT-11, a comptothecin derivative, in patients with primary lung cancer: CPT-11 co-operative study group [in Japanese], Gan To Kagaku Ryoho, 18, 1013 Baker, 1997, Phase II study of irinotecan in advanced non-small cell lung cancer (NSCLC), 16, A1658 Douillard, 1995, Phase II study of CPT-11 (irinotecan) in non-small cell lung cancer (NSCLC), 14, A1118 Cvitkovic, 1992, The current and future place of vinorelbine in cancer therapy, Drugs, 44, 36, 10.2165/00003495-199200444-00005 Crawford, 1996, Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer, J Clin Oncol, 14, 2774, 10.1200/JCO.1996.14.10.2774 LeChevalier, 1994, Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients, J Clin Oncol, 12, 360, 10.1200/JCO.1994.12.2.360 Depierre, 1991, A phase II study of navelbine (vinorelbine) in the treatment of non-small cell lung cancer, Am J Clin Oncol, 14, 115, 10.1097/00000421-199104000-00004 Schabel, 1979, Cisdiamminedichloroplatinum: combination chemotherapy and cross resistance studies with tumors of mice, Cancer Treat Rep, 63, 1459 Parker, 1993, Taxol effect on cisplatin sensitivity and cisplatin cellular accumulation in human ovarian cancer cell, Monogr Natl Cancer Inst, 15, 83 Jekunen, 1994, Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro, Br J Cancer, 69, 299, 10.1038/bjc.1994.55 Rowinsky, 1991, Sequences of taxol and cisplatin: a phase I pharmacologic study, J Clin Oncol, 9, 1692, 10.1200/JCO.1991.9.9.1692 LeBlanck, 1992, Platinum anticancer drugs modulate p-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats, Cancer Res, 52, 540 Pirker, 1995, Paclitaxel/cisplatin in advanced non-small cell lung cancer (NSCLC), Ann Oncol, 6, 833, 10.1093/oxfordjournals.annonc.a059324 Klastersky, 1995, Cisplatin plus taxol in non-small cell lung cancer, 36, A1423 Rowinsky, 1993, Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony stimulating factor: neuromuscular toxicity is dose limiting, J Clin Oncol, 11, 2010, 10.1200/JCO.1993.11.10.2010 Belli, 1995, Phase I-II trial of paclitaxel (Taxol) and cisplatin in previously untreated advanced non-small cell lung cancer (NSCLC), 14, A1058 Bonomi, 1996, Phase III trial comparing etoposide (E) cisplatin (C) versus taxol (T) with cisplatin-GCSF (G) versus taxol-cisplatin in advanced non-small cell lung cancer: Eastern Cooperative Oncology Group (ECOG), 15, A1145 Langer, 1995, Paclitaxel and carboplatin in combination in the treatment of advanced non-small cell lung cancer: a phase II toxicity, response and survival analysis, J Clin Oncol, 13, 1860, 10.1200/JCO.1995.13.8.1860 Kearns, 1995, Reduced platelet toxicity with combination carboplatin and paclitaxel: pharmacodynamic modulation of carboplatin associated thrombocytopenia, 14, A364 Bunn, 1995, A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center Study, Semin Oncol, 22, 2 Johnson, 1996, Paclitaxel plus carboplatin in advanced non-small cell lung cancer: a phase II trial, J Clin Oncol, 14, 2054, 10.1200/JCO.1996.14.7.2054 Roa, 1996, Carboplatin and paclitaxel for chemotherapy naive patients with advanced non-small cell lung cancer, 15, A1231 Rowinsky, 1995, Phase I study of palitaxel as a 3 hour infusion followed by carboplatin in untreated patients with stage IV non-small cell lung cancer, Semin Oncol, 22, 48 Giaccone, 1995, Dose finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer, Semin Oncol, 22, 78 LeChevalier, 1995, Phase II study of docetaxel (Taxotere) and cisplatin in advanced non-small cell lung cancer (NSCLC), 14, A1059 Cle, 1995, Phase I–II study of cisplatin plus docetaxel (Taxotere) in non-small cell lung cancer (NSCLC), 14, A1087 Zalcberg, 1995, Preliminary results of the first phase II trial of docetaxel in combination with cisplatin in patients with metastatic or localy advanced non-small cell lung cancer (NSCLC), 14, A1062 Gebbia, 1994, Vinorelbine plus cisplatinum for the treatment of stage IIIB and IV non small cell lung carcinoma, Anticancer Res, 14, 1247 Berthaud, 1992, Phase I–II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer, Eur J Cancer, 28A, 1863, 10.1016/0959-8049(92)90023-U LeChevalier, 1994, Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients, J Clin Oncol, 12, 360, 10.1200/JCO.1994.12.2.360 Wozniak, 1996, Randomized phase III trial of cisplatin (CDDP) vs CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): report of a Southwest Oncology Group study (SWOG-9308), 15, A1110 Peters, 1995, Interaction between cisplatin and gemcitabine in vitro and in vivo, Semin Oncol, 22, 72 Shepherd, 1996, Phase II study of gemcitabine and cisplatin weekly times three every 4 weeks in patients with non-small cell lung cancer (NSCLC), 15, A1135 Shepherd, 1996, Phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer: usefulness of a mathematical model to determine maximum tolerable dose, J Clin Oncol, 14, 1656, 10.1200/JCO.1996.14.5.1656 Sandler, 1995, Gemcitabine plus cisplatin in non-small cell lung cancer (NSCLC): a phase II study, Eur J Cancer, 131A, S225, 10.1016/0959-8049(95)96325-8 Anton, 1997, Gemcitabine plus cisplatin in advanced NSCLC: final phase II results in combination with cisplatin in advanced non-small cell lung cancer, 15, A1656 Abratt, 1997, Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small cell lung cancer, J Clin Oncol, 15, 744, 10.1200/JCO.1997.15.2.744 Crino, 1997, Cisplatin-gemcitabine in combination in advanced non-small cell lung cancer (NSCLC): a phase II study, J Clin Oncol, 15, 297, 10.1200/JCO.1997.15.1.297 Stewart, 1995, Phase I/II study of cisplatin in combination with gemcitabine in non-small cell lung cancer (NSCLC), 14, A1064 Cardenal, 1997, Gemcitabine plus cisplatin versus etoposide plus cisplatin in advanced non-small cell lung cancer patients: preliminary randomized phase III results, 16, A1648 Masuda, 1992, CPT-11 in combination with cisplatin for advanced non-small cell lung cancer, J Clin Oncol, 10, 1775, 10.1200/JCO.1992.10.11.1775 Nakagawa, 1993, Phase II study of irinotecan (CPT-11) and cisplatin in patients with advanced NSCLC, 12, A1104 DeVore, 1997, Phase II trial of irinotecan (CPT-11) plus cisplatin (CDDP) in advanced NSCLC, 16, A1674 Fossella, 1995, Phase II study of docataxel for advanced or metastatic platinum refractory non-small cell lung cancer, J Clin Oncol, 13, 645, 10.1200/JCO.1995.13.3.645 Hainsworth, 1995, Paclitaxel by 1 hour infusion: an active drug in metastatic non-small cell lung cancer, J Clin Oncol, 13, 1609, 10.1200/JCO.1995.13.7.1609 Ruckdeschel, 1994, Second-line chemotherapy for resistant metastatic non-small cell lung cancer (NSCLC): the role of Taxol, 13, A1200 Santoro, 1994, Second line with vinorelbine in the weekly monochemotherapy for the treatment of advanced non small cell lung cancer, Lung Cancer, 11, 130, 10.1016/0169-5002(94)94270-6 Nitani, 1994, Clinical development of irinotecan (CPT-11) in lung cancers, Lung Cancer, 11, 30 Crino, 1997, Salvage therapy with gemcitabine (GEM) in pretreated, advanced non-small cell lung cancer (NSCLC), 16, A1603